-
spill-acid-on-myself reblogged this from mycology
-
bubaleh liked this
-
viletemptress reblogged this from earthcraft
-
chubbymushroom reblogged this from earthcraft
-
earthcraft reblogged this from yourwonderingmind
-
deejaydodd liked this
-
evanjeezy reblogged this from seansagisi and added:
That’s why Mario’s so buff.
-
seansagisi reblogged this from mindbabies and added:
Gotta love advancements in modern medicine!
-
mishamishimish liked this
-
sinembargolosito liked this
-
sinembargolosito reblogged this from gnarlyfe
-
sacradelicious liked this
-
atomic-oxygen liked this
-
mycology reblogged this from gnarlyfe
-
velveteenrabbit liked this
-
themarmalade liked this
-
wildfflowers liked this
-
myimpossiblesoul liked this
-
verdantdruid liked this
-
underverse liked this
-
latashawilliams liked this
-
amaranthinehaze liked this
-
luxnatura reblogged this from gnarlyfe and added:
FDA APPROVED PSYCHEDELIC THERAPY: New research shows psychedelics might hold therapeutic potential for those dealing...
-
bluehum reblogged this from thediscography
-
bradjunswick liked this
-
jipc reblogged this from buddhabrot
-
little-feather liked this
-
joneven liked this
-
jipc liked this
-
gnarlyfe reblogged this from buddhabrot
-
m0onbaby reblogged this from buddhabrot
-
themoonishere liked this
-
geranium-kisser liked this
-
m0onbaby liked this
-
buddhabrot reblogged this from commondense
-
commondense reblogged this from victorioushandofgod
-
optimistowl reblogged this from metaconscious
-
thestandingpost liked this
-
lookfar reblogged this from motionsensorsoundtrack
-
wearealone liked this
-
thebarmaiden liked this
-
a-golden-lion liked this
-
llbwwb liked this
-
like-butter reblogged this from poortaste
-
like-butter liked this
-
carolinepulaskiday reblogged this from zefrancisco
-
zefrancisco reblogged this from lazergazerz
-
lazergazerz reblogged this from roads2roam and added:
i believe whole heartedly in the potential positive impact this type of therapy will produce!! so happy to read this!
-
roads2roam reblogged this from poortaste
-
jaeboogie liked this
- Show more notes
Ask ·
We all have some friend, perhaps more often feminine than masculine, and young than old, whose soul is of this sky-blue tint, whose affinities are rather with flowers and birds and all enchanting innocencies than with dark human passions, who can think no ill of man or God, and in whom religious gladness, being in possession from the outset, needs no deliverance from any antecedent burden.
![FDA APPROVED PSYCHEDELIC THERAPY: New research shows psychedelics might hold therapeutic potential for those dealing with death
The Food and Drug Administration has approved the use of psilocybin, the active ingredient of psychedelic mushrooms, in pilot clinical trials to treat end-of-life distress. [Credit: Rohan523, wikimedia.org]
“As doctors, we’re good at saving lives,” said Ross. “But we have not learned the art of helping patients have a good death.”
A 2007 study published by the American Cancer Society found that up to 50 percent of patients with advanced or terminal cancer are diagnosed with a major psychiatric disorder, and less than half of those with depressive symptoms receive any psychiatric medication. New treatment models could go a long way to help the over 500,000 Americans expected to die this year of cancer.
According to the researchers, psilocybin can achieve in one session what might otherwise take months or years, time some of these patients may not have.
Psilocybin binds to two types of serotonin receptors in the brain that are highly associated with mood and anxiety. Even more interesting to psychiatrists, brain imaging studies from the Heffter Research Center in Switzerland show that the drug appears to affect areas of the brain thought to mediate consciousness and spiritual feelings.
The effects of psilocybin last about four to six hours, during which time the subjects’ brain activity resembles that of people in spiritual states, such as meditating monks. Like people who practice meditation, the patients in the psilocybin trials reported feelings such as a greater connectedness to others, relief from fear and anxiety, and the ability to internalize their limited time as opportunities for personal growth.
▶ Read More at Science Line](http://24.media.tumblr.com/tumblr_kz3o6pR0Kg1qa31pso1_r1_500.jpg)
FDA APPROVED PSYCHEDELIC THERAPY: New research shows psychedelics might hold therapeutic potential for those dealing with death
The Food and Drug Administration has approved the use of psilocybin, the active ingredient of psychedelic mushrooms, in pilot clinical trials to treat end-of-life distress. [Credit: Rohan523, wikimedia.org]
“As doctors, we’re good at saving lives,” said Ross. “But we have not learned the art of helping patients have a good death.”
A 2007 study published by the American Cancer Society found that up to 50 percent of patients with advanced or terminal cancer are diagnosed with a major psychiatric disorder, and less than half of those with depressive symptoms receive any psychiatric medication. New treatment models could go a long way to help the over 500,000 Americans expected to die this year of cancer.
According to the researchers, psilocybin can achieve in one session what might otherwise take months or years, time some of these patients may not have.
Psilocybin binds to two types of serotonin receptors in the brain that are highly associated with mood and anxiety. Even more interesting to psychiatrists, brain imaging studies from the Heffter Research Center in Switzerland show that the drug appears to affect areas of the brain thought to mediate consciousness and spiritual feelings.
The effects of psilocybin last about four to six hours, during which time the subjects’ brain activity resembles that of people in spiritual states, such as meditating monks. Like people who practice meditation, the patients in the psilocybin trials reported feelings such as a greater connectedness to others, relief from fear and anxiety, and the ability to internalize their limited time as opportunities for personal growth.
▶ Read More at Science Line
